Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05681715 |
|---|---|
| Brief Title: | A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG) |
| First Submitted : | January 4, 2023 |
| First Submitted that Met QC Criteria : | January 4, 2023 |
| First Posted : | January 12, 2023 |
| Last Update Submitted that Met QC Criteria : | April 25, 2024 |
| Last Update Posted : | April 26, 2024 |